Glucosamine
For the symptomatic treatment of osteoarthritis and of joint discomfort.
What is it?
- Glucosamine is an amino sugar that is a precursor for the synthesis of glycosaminoglycans such as hyaluronic acid, which is a component of most connective tissues and therefore vital for joint health.
- It is a natural component of proteoglycans found in articular cartilage, intervertebral disc and synovial fluid.
- The older we get, the more cartilage gradually deteriorates, causing pain and discomfort.
Efficacy
- Glucosamine-API is considered a Symptomatic Slow Acting Drug for mild knee Osteoarthritis.
- Clinical trials demonstrate it reduces joint pain and improves mobility.
- Glucosamine supplied by Bioiberica is produced by hydrolysis of crustacean shells and is available for sale in the form of:
- Glucosamine Hydrochloride
- Glucosamine sulfate sodium chloride
- Glucosamine sulfate potassium chloride
- Bioiberica offers glucosamine as API for pharmaceuticals and nutraceutical quality glucosamine which is predominantly used as a main ingredient in nutraceutical and veterinary formulations.
- Our Glucosamine is compliant with the most restrictive and up-to-date monographs (EP, USP and RP) and is GMP certified.
Product information
- SOURCE: Exoskeletons of crustaceans.
- SALTS:
- Glucosamine hydrochloride
- Glucosamine sodium sulfate
- Glucosamine potassium sulfate
- USES:
- Pharmaceuticals
- Nutraceuticals
- QUALITIES: European, United States and Russian Pharmacopoeia.
- DMFs/CERTIFICATIONS: DMF for all qualities, Halal and GMP certificates.
- INDICATION: For the symptomatic treatment of mild knee osteoarthritis.
- PRESENTATION: Powder, white to almost white.
- RECOMMENDED DOSE: 1.500 mg/day
- REGULATORY STATUS: Active Pharmaceutical Ingredient and Dietary Supplement Ingredient.
- STORAGE AND PACKAGING: Store at room temperature. Packaged in a double bag in a 25 KG drum.
- RE-ANALYSIS/EXPIRATION PERIOD: Re-analysis period of two years from the manufacture date.
